Mark J. Rose

4.2k total citations · 1 hit paper
49 papers, 2.7k citations indexed

About

Mark J. Rose is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Mark J. Rose has authored 49 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Hematology. Recurrent topics in Mark J. Rose's work include Pharmacogenetics and Drug Metabolism (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Neuropeptides and Animal Physiology (4 papers). Mark J. Rose is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Neuropeptides and Animal Physiology (4 papers). Mark J. Rose collaborates with scholars based in United States, United Kingdom and Germany. Mark J. Rose's co-authors include Patrick G. Swann, Russell Weiner, Brian Booth, Surendra K. Bansal, Vinod P. Shah, Anthony J. DeStefano, C.T. Viswanathan, Jerome P. Skelly, Jeffrey Sailstad and Eric Woolf and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Mark J. Rose

47 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays

2007 667 citations Mark J. Rose et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Rose United States	23	794	535	422	334	292	49	2.7k
Francis L. S. Tse Japan	28	721 0.9×	585 1.1×	496 1.2×	270 0.8×	486 1.7×	110	2.7k
Eric Woolf United States	32	572 0.7×	499 0.9×	785 1.9×	268 0.8×	566 1.9×	96	2.7k
Brian Booth United States	30	1.6k 2.0×	815 1.5×	337 0.8×	1.3k 4.0×	223 0.8×	77	4.6k
Patrick G. Swann United States	18	1.4k 1.7×	658 1.2×	206 0.5×	209 0.6×	235 0.8×	26	2.5k
B.G. Wolthers Netherlands	32	1.5k 1.8×	444 0.8×	183 0.4×	478 1.4×	333 1.1×	132	3.7k
Anne‐Françoise Aubry United States	25	814 1.0×	349 0.7×	196 0.5×	226 0.7×	530 1.8×	70	1.8k
Kitaro Oka Japan	28	1.3k 1.6×	235 0.4×	332 0.8×	221 0.7×	213 0.7×	155	3.0k
Günter Fauler Austria	29	644 0.8×	277 0.5×	140 0.3×	349 1.0×	151 0.5×	88	2.5k
Teake Kooistra Netherlands	40	2.0k 2.5×	1.7k 3.1×	329 0.8×	472 1.4×	112 0.4×	97	6.4k

Countries citing papers authored by Mark J. Rose

Since Specialization

Citations

This map shows the geographic impact of Mark J. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Rose more than expected).

Fields of papers citing papers by Mark J. Rose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Rose. The network helps show where Mark J. Rose may publish in the future.

Co-authorship network of co-authors of Mark J. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Rose. A scholar is included among the top collaborators of Mark J. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Rose. Mark J. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marco, Annalise Di, Domenico Vignone, Odalys Gonzalez Paz, et al.. (2020). Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System. Cells. 9(4). 994–994. 27 indexed citations

Bruns, Brandon, et al.. (2020). Factors associated with refractory pain in emergency patients admitted to emergency general surgery. World Journal of Emergency Medicine. 12(1). 12–12. 1 indexed citations

Rose, Mark J., et al.. (2019). Ground Same Intratransport Efficacy as Air for Acute Aortic Diseases. Air Medical Journal. 38(3). 188–194. 6 indexed citations

Rose, Mark J., et al.. (2019). Assessing adequacy of emergency provider documentation among interhospital transferred patients with acute aortic dissection. World Journal of Emergency Medicine. 10(2). 94–94. 5 indexed citations

Rose, Mark J., et al.. (2016). 362: TRANSPORT TEAMS’ DOCUMENTATION OF INTERFACILITY TRANSFERRED PATIENTS WITH AORTIC DISSECTIONS. Critical Care Medicine. 44(12). 167–167. 1 indexed citations

Bashaw, Edward D., et al.. (2014). Bioanalytical Method Validation: Concepts, Expectations and Challenges in Small Molecule and Macromolecule—A Report of PITTCON 2013 Symposium. The AAPS Journal. 16(3). 586–591. 4 indexed citations

Li, Hongyan, et al.. (2011). Direct Quantitative Analysis of a 20 kDa PEGylated Human Calcitonin Gene Peptide Antagonist in Cynomolgus Monkey Serum Using In-Source CID and UPLC-MS/MS. Journal of the American Society for Mass Spectrometry. 22(9). 1660–1667. 17 indexed citations

James, Christopher, et al.. (2011). Development of a method for the determination of glycine in human cerebrospinal fluid using pre-column derivatization and LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 56(2). 315–323. 20 indexed citations

Carnahan, Josette, Pedro J. Beltran, Carol Babij, et al.. (2010). Selective and Potent Raf Inhibitors Paradoxically Stimulate Normal Cell Proliferation and Tumor Growth. Molecular Cancer Therapeutics. 9(8). 2399–2410. 58 indexed citations

10.

Xiao, Jim, Wojciech Krzyżański, Yow‐Ming Wang, et al.. (2010). Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys. The AAPS Journal. 12(4). 646–657. 68 indexed citations

11.

Sasu, Barbra J., Hongyan Li, Mark J. Rose, et al.. (2010). Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Molecules and Diseases. 45(3). 238–245. 33 indexed citations

12.

Li, Hongyan, Mark J. Rose, Jingwen Zhang, et al.. (2009). Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. Journal of Pharmacological and Toxicological Methods. 59(3). 171–180. 91 indexed citations

13.

Rose, Mark J., et al.. (2008). Management of the Mechanically Ventilated Patient in the Emergency Department. Journal of Emergency Nursing. 34(2). 121–125.

14.

Xu, Yang, Lihong Du, Mark J. Rose, et al.. (2005). Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine. Journal of Chromatography B. 818(2). 241–248. 31 indexed citations

15.

Rose, Mark J. & Clive Page. (2004). Glycosaminoglycans and the Regulation of Allergic Inflammation. Current Drug Targets - Inflammation & Allergy. 3(3). 221–225. 22 indexed citations

16.

Sandhu, Punam, John S. Vogel, Mark J. Rose, et al.. (2004). EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE. Drug Metabolism and Disposition. 32(11). 1254–1259. 45 indexed citations

17.

Barrow, James C., Philippe G. Nantermet, Shaun R. Stauffer, et al.. (2003). Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics. Journal of Medicinal Chemistry. 46(25). 5294–5297. 36 indexed citations

18.

Rose, Mark J., Eric Woolf, K. C. Yeh, et al.. (2000). High-throughput simultaneous determination of the HIV protease inhibitors indinavir and L-756423 in human plasma using semi-automated 96-well solid phase extraction and LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 24(2). 291–305. 25 indexed citations

19.

Rose, Mark J., et al.. (1999). Determination of L-756 423, a novel HIV protease inhibitor, in human plasma and urine using high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 732(2). 425–435. 4 indexed citations

20.

Rose, Mark J., et al.. (1997). Selective fluorogenic derivatization of a peptide nucleic acid trimer with naphthalene-2,3-dicarboxaldehyde. Journal of Pharmaceutical and Biomedical Analysis. 15(7). 945–950. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact